#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic kidney disease Adenocarcinoma pancreas Granulomatosis with polyangiitis Gestational trophoblastic tumour Skin angiosarcoma Crohn's disease Corneal neovascularisation Intracranial germ cell tumour Juvenile chronic myelomonocytic leukaemia Congenital myopathy Hereditary motor and sensory neuropathy Acquired haemophilia Hodgkin's disease Astrocytoma Testicular leiomyosarcoma More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Diagnostics Hereditary neuropathic amyloidosis – Basic Information Pleural mesothelioma malignant – Basic Information Systemic mastocytosis – Life with Disease Ocular melanoma – Trials in Disease Kearns-Sayre syndrome – Diagnostics Toxic epidermal necrolysis – Diagnostics Small intestine leiomyosarcoma – Basic Information Hairy cell leukaemia recurrent – Treatment Encephalitis autoimmune – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propofol Ursodoxicoltaurine Ertugliflozin Lysine Hydrochloride Stiripentol Adrc GSKVX000000039711 Surzebiclimab Tucatinib Omeprazole Berotralstat Napabucasin Ro7790121 Dl-Alpha Tocopherol Acetate Nebivolol Hydrochloride Bezafibrate Travoprost Magrolimab Rimegepant Lamivudine More therapies…

    Learn about Your Condition

    Acromegaly Adenovirus infection Glomerulonephritis membranous Hepatic neoplasm Orthostatic hypotension Skin wrinkling Univentricular heart Chronic myeloid leukaemia Coagulopathy Prodromal Alzheimer's disease Plasma cell myeloma Anal fistula Thyroid cancer metastatic Post-traumatic stress disorder Haemoptysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to investigate the safety and effectiveness of WEF-001 in patients with advanced KRAS-mutant solid tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • WEF-001
    Spain

  • Comparison of intrathecal baclofen pump and selective dorsal rhizotomy for children with cerebral palsy who cannot walk

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral palsy
    Investigated Drugs:
    • Baclofen
    Belgium The Netherlands

  • Study of Fast Awakening from General Anesthesia Using a Drug Combination Including Remimazolam in Healthy Volunteers

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Naloxone Hydrochloride
    • Rocuronium Bromide
    • Sufentanil Citrate
    The Netherlands

  • Testing the Safety of Dendritic Cell and CAR-T Cell Combination Therapy in Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Brain stem glioma
    Investigated Drugs:
    • ARI0008
    Spain

  • Study of regorafenib as maintenance treatment after first-line therapy in patients with bone sarcomas without remaining disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Bone sarcoma
    Investigated Drugs:
    • Regorafenib
    France

  • Testing acetylsalicylic acid and ketorolac to reduce complications after cancer surgery in patients with high inflammation levels

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Inflammation
    Investigated Drugs:
    • KETOROLAC TROMETAMOL
    • Acetylsalicylic Acid
    Italy
Previous Page
1 … 743 744 745 746 747 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!